BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34242226)

  • 21. Quantitative Analysis of Whole-Body MRI for Accessing the Degree of Diffuse Infiltration Patterns and Identifying High Risk Cases of Newly Diagnosed Multiple Myeloma.
    Sun M; Wang L; Wang C; Ma J; Wang W; Lin L; Ren C; Zhang Y; Cheng J
    J Magn Reson Imaging; 2024 Jun; 59(6):2035-2045. PubMed ID: 37675995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apparent diffusion coefficient of vertebral haemangiomas allows differentiation from malignant focal deposits in whole-body diffusion-weighted MRI.
    Winfield JM; Poillucci G; Blackledge MD; Collins DJ; Shah V; Tunariu N; Kaiser MF; Messiou C
    Eur Radiol; 2018 Apr; 28(4):1687-1691. PubMed ID: 29134357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole-body MRI, dynamic contrast-enhanced MRI, and diffusion-weighted imaging for the staging of multiple myeloma.
    Dutoit JC; Verstraete KL
    Skeletal Radiol; 2017 Jun; 46(6):733-750. PubMed ID: 28289855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole-body MRI to assess bone involvement in prostate cancer and multiple myeloma: comparison of the diagnostic accuracies of the T1, short tau inversion recovery (STIR), and high b-values diffusion-weighted imaging (DWI) sequences.
    Larbi A; Omoumi P; Pasoglou V; Michoux N; Triqueneaux P; Tombal B; Cyteval C; Lecouvet FE
    Eur Radiol; 2019 Aug; 29(8):4503-4513. PubMed ID: 30413957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deep Learning for Automatic Bone Marrow Apparent Diffusion Coefficient Measurements From Whole-Body Magnetic Resonance Imaging in Patients With Multiple Myeloma: A Retrospective Multicenter Study.
    Wennmann M; Neher P; Stanczyk N; Kahl KC; Kächele J; Weru V; Hielscher T; Grözinger M; Chmelik J; Zhang KS; Bauer F; Nonnenmacher T; Debic M; Sauer S; Rotkopf LT; Jauch A; Schlamp K; Mai EK; Weinhold N; Afat S; Horger M; Goldschmidt H; Schlemmer HP; Weber TF; Delorme S; Kurz FT; Maier-Hein K
    Invest Radiol; 2023 Apr; 58(4):273-282. PubMed ID: 36256790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic accuracy of whole-body diffusion-weighted magnetic resonance imaging with 3.0 T in detection of primary and metastatic neoplasms.
    Akay S; Kocaoglu M; Emer O; Battal B; Arslan N
    J Med Imaging Radiat Oncol; 2013 Jun; 57(3):274-82. PubMed ID: 23721135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of naive indolent lymphoma using whole-body diffusion-weighted imaging and T2-weighted MRI: results of a prospective study in 30 patients.
    Hong GS; Chae EJ; Ryu JS; Chae SY; Lee HS; Yoon DH; Suh C
    Cancer Imaging; 2021 Jan; 21(1):5. PubMed ID: 33413685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic performance of
    Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
    Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma.
    Gutzeit A; Doert A; Froehlich JM; Eckhardt BP; Meili A; Scherr P; Schmid DT; Graf N; von Weymarn CA; Willemse EM; Binkert CA
    Skeletal Radiol; 2010 Apr; 39(4):333-43. PubMed ID: 20205350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Learning curves in radiological reporting of whole-body MRI in plasma cell disease: a retrospective study.
    Negroni D; Cassarà A; Trisoglio A; Soligo E; Berardo S; Carriero A; Stecco A
    Radiol Med; 2021 Nov; 126(11):1451-1459. PubMed ID: 34309766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole-body MRI quantitative biomarkers are associated significantly with treatment response in patients with newly diagnosed symptomatic multiple myeloma following bortezomib induction.
    Latifoltojar A; Hall-Craggs M; Bainbridge A; Rabin N; Popat R; Rismani A; D'Sa S; Dikaios N; Sokolska M; Antonelli M; Ourselin S; Yong K; Taylor SA; Halligan S; Punwani S
    Eur Radiol; 2017 Dec; 27(12):5325-5336. PubMed ID: 28656463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole-body diffusion-weighted MRI with apparent diffusion coefficient mapping for early response monitoring in multiple myeloma: preliminary results.
    Horger M; Weisel K; Horger W; Mroue A; Fenchel M; Lichy M
    AJR Am J Roentgenol; 2011 Jun; 196(6):W790-5. PubMed ID: 21606271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic Value of Whole-Body DWI With Background Body Suppression Plus Calculation of Apparent Diffusion Coefficient at 3 T Versus
    Sun W; Li M; Gu Y; Sun Z; Qiu Z; Zhou Y
    AJR Am J Roentgenol; 2020 Feb; 214(2):446-454. PubMed ID: 31799866
    [No Abstract]   [Full Text] [Related]  

  • 34. Assessing extracranial tumors using diffusion-weighted whole-body MRI.
    Lenz C; Klarhöfer M; Scheffler K; Winter L; Sommer G
    Z Med Phys; 2011 May; 21(2):79-90. PubMed ID: 20888200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diffusion-weighted imaging for non-invasive and quantitative monitoring of bone marrow infiltration in patients with monoclonal plasma cell disease: a comparative study with histology.
    Hillengass J; Bäuerle T; Bartl R; Andrulis M; McClanahan F; Laun FB; Zechmann CM; Shah R; Wagner-Gund B; Simon D; Heiss C; Neben K; Ho AD; Schlemmer HP; Goldschmidt H; Delorme S; Stieltjes B
    Br J Haematol; 2011 Jun; 153(6):721-8. PubMed ID: 21517815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of DWIBS in malignant lymphoma: correlation between ADC values and Ki-67 index.
    Sun M; Cheng J; Zhang Y; Bai J; Wang F; Meng Y; Li Z
    Eur Radiol; 2018 Apr; 28(4):1701-1708. PubMed ID: 29143105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiation of Diffuse Infiltration Pattern in Multiple Myeloma From Hyperplastic Hematopoietic Bone Marrow: Qualitative and Quantitative Analysis Using Whole-Body MRI.
    Sun M; Cheng J; Ren C; Zhang Y; Li Y; Wang L; Liu Y
    J Magn Reson Imaging; 2022 Apr; 55(4):1213-1225. PubMed ID: 34558141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal monitoring of apparent diffusion coefficient (ADC) in myeloma patients with lower M-gradient levels undergoing systemic treatment and whole-body MRI monitoring.
    Perl RM; Gronbach F; Fritz J; Horger MS; Hepp T
    Eur J Radiol; 2020 Nov; 132():109306. PubMed ID: 33038578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pictorial review of whole body MRI in myeloma: emphasis on diffusion-weighted imaging.
    Hameed M; Sandhu A; Soneji N; Amiras D; Rockall A; Messiou C; Wallitt K; Barwick TD
    Br J Radiol; 2020 Nov; 93(1115):20200312. PubMed ID: 32667830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffusion-weighted whole-body MRI for evaluation of early response in multiple myeloma.
    Lacognata C; Crimì F; Guolo A; Varin C; De March E; Vio S; Ponzoni A; Barilà G; Lico A; Branca A; De Biasi E; Gherlinzoni F; Scapin V; Bissoli E; Berno T; Zambello R
    Clin Radiol; 2017 Oct; 72(10):850-857. PubMed ID: 28587715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.